Safety and preliminary efficacy of allogeneic umbilical cord-derived mesenchymal stem cells administered via the hepatic artery in patients with liver cirrhosis: A phase I open-label trial.

Nguyen LT et al.

NCBI PubMed Central · Papers · License: Open Access

distributed systems architecture

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 236186
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.